FDA Approval: Blinatumomab.

MLA

Przepiorka, Donna, et al. “FDA Approval: Blinatumomab.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 21, no. 18, Sept. 2015, pp. 4035–39. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-15-0612.

APA

Przepiorka, D., Ko, C.-W., Deisseroth, A., Yancey, C. L., Candau-Chacon, R., Chiu, H.-J., Gehrke, B. J., Gomez-Broughton, C., Kane, R. C., Kirshner, S., Mehrotra, N., Ricks, T. K., Schmiel, D., Song, P., Zhao, P., Zhou, Q., Farrell, A. T., & Pazdur, R. (2015). FDA Approval: Blinatumomab. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(18), 4035–4039. https://doi.org/10.1158/1078-0432.CCR-15-0612

Chicago

Przepiorka, Donna, Chia-Wen Ko, Albert Deisseroth, Carolyn L Yancey, Reyes Candau-Chacon, Haw-Jyh Chiu, Brenda J Gehrke, et al. 2015. “FDA Approval: Blinatumomab.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 21 (18): 4035–39. doi:10.1158/1078-0432.CCR-15-0612.